171 related articles for article (PubMed ID: 8123683)
1. Effect on human platelet aggregation of phospholipase A2 purified from Heloderma horridum (beaded lizard) venom.
Huang TF; Chiang HS
Biochim Biophys Acta; 1994 Feb; 1211(1):61-8. PubMed ID: 8123683
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of the phospholipase A2 purified from the venom of the Mexican beaded lizard (Heloderma horridum horridum Wiegmann).
Sosa BP; Alagón AC; Martin BM; Possani LD
Biochemistry; 1986 May; 25(10):2927-33. PubMed ID: 3087412
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibitory action on platelet activation of a phospholipase A2 isolated from Lachesis muta (Bushmaster) snake venom.
Fuly AL; Machado OL; Alves EW; Carlini CR
Thromb Haemost; 1997 Nov; 78(5):1372-80. PubMed ID: 9408022
[TBL] [Abstract][Full Text] [Related]
4. Isolation of an acidic phospholipase A2 from the venom of Agkistrodon acutus (five pace snake) and its effect on platelet aggregation.
Chen RH; Chen YC
Toxicon; 1989; 27(6):675-82. PubMed ID: 2749764
[TBL] [Abstract][Full Text] [Related]
5. Effect of the purified phospholipases A2 from snake and bee venoms on rabbit platelet function.
Ouyang C; Huang TF
Toxicon; 1984; 22(5):705-18. PubMed ID: 6441310
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
8. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterisation of a snake venom phospholipase A2: a potent inhibitor of platelet aggregation.
Yuan Y; Jackson SP; Mitchell CA; Salem HH
Thromb Res; 1993 Jun; 70(6):471-81. PubMed ID: 8362372
[TBL] [Abstract][Full Text] [Related]
10. Purification of a Class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja Naja) venom.
Satish S; Tejaswini J; Krishnakantha TP; Gowda TV
Biochimie; 2004 Mar; 86(3):203-10. PubMed ID: 15134835
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
Ding YA; Chou TC; Chern JW; Yen MH
Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
[TBL] [Abstract][Full Text] [Related]
12. Venom from southern copperhead snake (Agkistrodon contortrix contortrix). II. A unique phospholipase A2 that induces platelet aggregation.
Takagi J; Sekiya F; Kasahara K; Inada Y; Saito Y
Toxicon; 1988; 26(2):199-206. PubMed ID: 3363567
[TBL] [Abstract][Full Text] [Related]
13. A novel monogalactosylacylglycerol with inhibitory effect on platelet aggregation from the cyanophyceae Oscillatoria rosea.
Rho MC; Matsunaga K; Yasuda K; Ohizumi Y
J Nat Prod; 1996 Mar; 59(3):308-9. PubMed ID: 8882435
[TBL] [Abstract][Full Text] [Related]
14. BE-I-PLA2, a novel acidic phospholipase A2 from Bothrops erythromelas venom: isolation, cloning and characterization as potent anti-platelet and inductor of prostaglandin I2 release by endothelial cells.
de Albuquerque Modesto JC; Spencer PJ; Fritzen M; Valença RC; Oliva ML; da Silva MB; Chudzinski-Tavassi AM; Guarnieri MC
Biochem Pharmacol; 2006 Jul; 72(3):377-84. PubMed ID: 16750518
[TBL] [Abstract][Full Text] [Related]
15. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
Huang TF; Sheu JR; Teng CM
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
[TBL] [Abstract][Full Text] [Related]
16. Role of catalytic function in the antiplatelet activity of phospholipase A2 cobra (Naja naja naja) venom.
Rudrammaji LM; Machiah KD; Kantha TP; Gowda TV
Mol Cell Biochem; 2001 Mar; 219(1-2):39-44. PubMed ID: 11354251
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of a platelet aggregation inhibitor acidic phospholipase A2 from Indian saw-scaled viper (Echis carinatus) venom.
Kemparaju K; Krishnakanth TP; Veerabasappa Gowda T
Toxicon; 1999 Dec; 37(12):1659-71. PubMed ID: 10519645
[TBL] [Abstract][Full Text] [Related]
18. Effect of cobra venom phospholipase A2 on platelet aggregation in comparison with those produced by arachidonic acid and lysophophatidylcholine.
Teng CM; Kuo YP; Lee LG; Ouyang C
Thromb Res; 1986 Dec; 44(6):875-86. PubMed ID: 3099424
[TBL] [Abstract][Full Text] [Related]
19. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet actions of some coumarin compounds isolated from plant sources.
Teng CM; Li HL; Wu TS; Huang SC; Huang TF
Thromb Res; 1992 Jun; 66(5):549-57. PubMed ID: 1523611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
